Synchron
Users implanted with Synchron’s BCI will be able to control iPhone, iPad and Apple Vision Pro with their thoughts without physical movement or voice commands.
Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.
The company hopes this study will be a stepping stone towards regulatory approval of its product.
Also: Phil scores $100 million for its prescription refill platform and Synchron rakes in $40 million.